In a compelling piece from TechBuzz News, Videra Health’s Brett Talbot explores how AI-driven assessment—originally designed for behavioral health—is unlocking new possibilities in the detection and monitoring of movement disorders. The article highlights how shared challenges across disciplines, like episodic data gaps and subjective ratings, can be addressed by AI’s continuous, multimodal analysis. This convergence signals a future where digital biomarkers create more precise, scalable, and patient-centered tools across the healthcare spectrum. As AI continues to bridge domains, it holds the potential to dramatically reshape both clinical practice and pharmaceutical innovation. Read the full article here.